Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876522 · ClinicalTrials.gov registry record
Natural History and Functional Status Study of Patients With Lafora Disease
A clinical trial, sponsored by Ionis Pharmaceuticals.
- Completed
- Registry status
- 33
- Enrollment target
NCT03876522 is a clinical trial that has completed, run by Ionis Pharmaceuticals. The registered enrollment target is 33 participants.
The verdict
NCT03876522 has completed, sponsored by Ionis Pharmaceuticals.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
A natural history and functional status study to characterize the clinical disease course in Lafora disease patients using standardized, quantitative evaluations and to identify useful biomarkers and clinical outcome measures for use in future Lafora treatment studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-01-09 |
| Est. Completion | 2022-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03876522
The ClinicalTrials.gov registry entry for NCT03876522 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ionis Pharmaceuticals, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03876522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03876522 about?
NCT03876522 is a clinical study titled "Natural History and Functional Status Study of Patients With Lafora Disease". A natural history and functional status study to characterize the clinical disease course in Lafora disease patients using standardized, quantitative evaluations and to identify useful biomarkers and clinical outcome measures for use in future Lafora treatment studies.
What is the current status of trial NCT03876522?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2019-01-09. Estimated completion is 2022-04-01.
Who is sponsoring clinical trial NCT03876522?
This trial is sponsored by Ionis Pharmaceuticals, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.